Randall B. Sunberg

Email: rsunberg@morganlewis.com

Princeton
502 Carnegie Center
Princeton, NJ 08540-6289
Phone: 609.919.6606
Fax: 609.919.6701

education

New York University School of Law, 1982, J.D.

Yale University, 1977, B.A.

Publications

Date	Title	Publication
06/16/0906/16/09	BioBucks Meets PharmacoEconomics: Who's Got the Negotiating Leverage Now? presented at Allicense Conference, San Francisco	Speech
03/11/0903/11/09	Tales from the Front: Lessons Learned, Best Practices, and What to Avoid, presented at ACI's Life Sciences M&A Conference, New York	Speech
11/12/0811/12/08	Factoring Takeaways from Recent Deals and Trends, presented at ACI's Pharma/Biotech Collaborative Agreements Conference, New York	Speech
11/10/0811/10/08	Strategic Crossroads: Build, Buy, or Partner for Commercialization Capabilities, presented at Biotech 2008, Philadelphia	Speech
06/19/0806/19/08	From Europe and Japan to the U.S.: Build or Buy?, presented at the 2008 BIO International Convention, San Diego, CA	Speech
03/12/0803/12/08	Getting to the Heart of the Business Reasons Behind the Deal and Finding the Right Partner, presented at ACI's Life Sciences Mergers and Acquisitions Conference, New York	Speech
05/05/0705/05/07	Biotech and Pharma Partnering: Current Trends in Global Deals, presented at the Sino-American Pharmaceutical Professionals Association 2007 Annual Conference, Philadelphia	Speech
03/14/0703/14/07	Unique Challenges in Private Versus Public Life Sciences M&A, presented to the American Conference Institute, New York	Speech
02/14/0702/14/07	The Anatomy of a Deal: Dissecting the Bio-Bucks, presented at the BIO CEO and Investor Conference, New York	Speech
10/16/0610/16/06	Mid-Stage Company Exit Strategies: Path to Glory?, presented at Biotech 2006, Philadelphia View Presentation	Speech
09/13/0609/13/06	Finance Sector Mini-Plenary Session, presented at the LES Annual Meeting, New York	Speech
09/11/0609/11/06	From Term Sheet to Contract: A Roadmap for Biotech and Pharma Collaborations, presented at the LES Annual Meeting, New York	Speech
04/17/0604/17/06	Creative Financing for Biotech and Pharma Drug Development and Commercialization, presented at the New York Biotechnology Association Annual Meeting View Speech	Speech
02/09/0602/09/06	Mergers and Acquisitions: What Every In-House Lawyer Needs to Know, presented at the Association of Corporate Counsel - New Jersey (NJCCA) Chapter, Whippany, NJ	Speech
07/30/0507/30/05	Current Trends and Provisions in Pharma-Biotech Strategic Alliances, presented at the International Forum on Biotech Commercialization in Greater China/Asia Pacific, Rutgers Business School, NJ View Speech	Speech
06/08/0506/08/05	Partnering with Large Pharma, presented at the New Jersey Technology Council Commercialization Center for Innovative Technologies, NJ View Presentation	Speech
03/30/0503/30/05	Pharma-Biotech Negotiation Workshop, presented at BIOMEDEX 2005, Montreal View Presentation	Speech
10/29/0410/29/04	Making 50-50 Collaborations Work Effectively, presented to JP Morgan Chase, Newport Conference Center View Presentation	Speech
10/17/0410/17/04	Biotech and Pharma M&A and Collaborations: Protecting the Deal and Preserving Your Upside, LES Annual Meeting, Boston View Speech	Speech
10/05/0410/05/04	Biotech and Pharma M&A and Collaborations: Protecting the Deal and Preserving Your Upside, presented at Biotech 2004, Philadelphia View Presentation	Speech
07/24/0407/24/04	Strategic Alliances and Business Development, presented at the BioForum 2004, Shanghai View Presentation	Speech
02/13/0402/13/04	Protecting Your Downside While Maximizing Your Upside: Protective Provisions in Biotech Deals, presented at the LES Winter Meeting, San Francisco View Presentation	Speech
09/09/0309/09/03	Pharma and Biotech Collaborations, PA Biotech, 3 Rivers Venture Fair View Speech	Speech
06/24/0306/24/03	Getting from Biotech to BIG Biotech, BIO 2003, Washington, DC View Speech	Speech
04/30/0304/30/03	Closing Plenary Session: Facilitating Global Reach in the Life Sciences Industry, BIOTechnica America, Monterey, CA View Speech	Speech
01/30/0301/30/03	M&A and Alternative Strategic Alliances in the Pharmaceutical Industry: On the Road to Consolidation	Speech
10/22/0210/22/02	Promotion and Development Collaborations Between Established Players, presented at the American Conference Institute, New York View Presentation	Speech
09/30/0209/30/02	Law & Biotechnology, presented at Biotech 2002, Philadelphia	Speech
06/01/0206/01/02	Pharmaceutical/Biotechnology M&A and Corporate Partnering	Speech
04/17/0204/17/02	Outline of Issues to Consider in Preparing for an IPO for a Life Science Company	Speech
04/01/0104/01/01	Biotechnology and the Law: Patent Developments and Licensing Trends, presented at Biotech 2001, Philadelphia View Presentation	Speech
04/01/01April 2001	Top Ten Key Legal Issues to Consider When Drafting Internet-Based Outsourcing Agreements, New Jersey Tech News	Article
01/25/0101/25/01	Legal Issues Impacting Health Care Venture Capitalists, presented at the Equity Research Private Healthcare Company Conference, Princeton	Speech
03/29/0003/29/00	Breakthrough: Management Issues Facing a Growing Biotechnology Company, presented at BIO 2000, Boston	Speech

Date	Title	Description
Dec 20, 2006	Morgan Lewis's Life Sciences Practice Recognized in ^PLCCross-border Life Sciences Handbook	Morgan Lewis is pleased to announce that the Life Sciences Interdisciplinary Practice and several of its attorneys are recognized in the ^PLCCross-border Life Sciences Handbook 2006/07.
Dec 13, 2005	Morgan Lewis’ Life Sciences Practice Recommended in ^PLC Cross-border Life Sciences Handbook	Morgan Lewis is pleased to announce that Practical Law Company recommends the firm’s Life Sciences Practice and its attorneys in the ^PLCCross-border Life Sciences Handbook 2005/06.

practice areas

bar admissions

Randall B. Sunberg

education

Publications

News